Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysis. Ko A, Chang YC, Bahar F, Wang TH, et al. Ann Intern Med 2026;179:216-229.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ko A, Chang YC, Bahar F, Wang TH, et al. Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysis. Ann Intern Med 2026;179:216-229.
PMID: 41359966